MedTrace Logo

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

NCT01521039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 259

Last updated 2025-01-20

No results posted yet for this study

Summary

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease (GVHD).

Conditions

  • Acute Graft-versus-Host Disease
  • Allogeneic Stem Cell Transplant

Interventions

PROCEDURE

Blood samples

2-3 tablespoons of blood weekly for the first 100 days (about 14 weeks) following allogeneic transplant. In addition a blood sample will be obtained before starting the chemotherapy or radiation regimen for the transplant, in the day of the transplant and if your doctor suspects that you have acute graft-versus-host disease.

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Hannah Choe, MD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-20
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01521039 on ClinicalTrials.gov